Web Analytics

Investor Profile

Alexandria Real Estate Equities, Inc.

Alexandria Real Estate Equities, Inc. United States - Pasadena, California
INVESTOR

1 Disclosed Funding Rounds $100,000,000
23 Participating Investments




Alexandria Real Estate Equities, Inc. (NYSE:ARE), an S&P 500® urban office real estate investment trust (REIT), pioneered the life science real estate niche and remains the longest-tenured ow

Invested In

Company Date Round Raised
  Matchpoint Therapeutics October, 17 ,2022 Series A $100,000,000
  Ensoma February, 06 ,2023 Series B $85,000,000
  Function Oncology April, 13 ,2023 Series A $28,000,000
  Orbital Therapeutics April, 27 ,2023 Unknown $270,000,000
  Boundless Bio May, 17 ,2023 Series C $100,000,000
  Solu Therapeutics August, 01 ,2023 Seed $31,000,000
  Georgiamune Inc. August, 10 ,2023 Series A $75,000,000
  Alto Neuroscience November, 22 ,2023 Series C $45,000,000
  Odyssey Therapeutics December, 06 ,2023 Series C $101,000,000
  Ability Biologics December, 07 ,2023 Seed $12,000,000
  Tome Biosciences December, 14 ,2023 Series B $213,000,000
  Remix Therapeutics January, 04 ,2024 Unknown $60,000,000
  Tr1X January, 19 ,2024 Series A $75,000,000
  Elo Life Systems January, 25 ,2024 Series A $20,500,000
  Capstan Therapeutics March, 21 ,2024 Series B $175,000,000
  Mirador Therapeutics March, 26 ,2024 Unknown $400,000,000
  OverT Bio May, 07 ,2024 Seed $16,000,000
  Delphia Therapeutics May, 07 ,2024 Series A $67,000,000
  TwoStep Therapeutics June, 26 ,2024 Seed $6,500,000
  Outpace Bio August, 02 ,2024 Series B $144,000,000
  Archon Biosciences October, 31 ,2024 Seed $20,000,000
  Leal Therapeutics October, 31 ,2024 Unknown $45,000,000
  CrossBridge Bio November, 05 ,2024 Unknown $10,000,000